Off-label use of omalizumab in non-asthma conditions: new opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Off-label use of omalizumab in non-asthma conditions: new opportunities

Published:2009-06 Issue:3 Volume:3 Page:299-308
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Morjaria Jaymin B,Polosa Riccardo

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1586/ers.09.11

Reference92 articles.

1. Induction and regulation of the IgE response

2. Anti-IgE in allergic asthma and rhinitis: an update

3. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation

4. Structure and Functions of CD23

5. Nasal sensitization

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. News in the treatment of bronchial asthma in adults;Interní medicína pro praxi;2016-07-01

2. A General and Robust Framework for Secondary Traits Analysis;Genetics;2016-02-18

3. Tailored therapy for severe asthma;Multidisciplinary Respiratory Medicine;2015-01-16

4. Omalizumab for Difficult-to-Treat Dermatological Conditions: Clinical and Immunological Features from a Retrospective Real-Life Experience;Clinical Drug Investigation;2015-01-13

5. Biologic therapy for atopic asthma and beyond;Current Opinion in Allergy & Clinical Immunology;2013-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP